8-hydroxy-2-(di-n-propylamino)tetralin and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Empson, RM; Gloveli, T; Heinemann, U; Schmitz, D1

Other Studies

1 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

ArticleYear
Serotonin reduces polysynaptic inhibition via 5-HT1A receptors in the superficial entorhinal cortex.
    Journal of neurophysiology, 1998, Volume: 80, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Entorhinal Cortex; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Free Radical Scavengers; Membrane Potentials; Neural Inhibition; Organ Culture Techniques; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses

1998